effects of semaglutide on chronic kidney disease Safety and Efficacy in Patients With Disease, With or Without Type 2 Diabetes: A Systematic Review and Meta‐Analysis Semaglutides Are Poised to Remake

112 Dulaglutide is a once-weekly long-acting GLP-1RA

Plaintiffs allege the companies did not adequately disclose the risk that the drugs could severely slow stomach emptying, leaving patients and doctors unaware of the potential complication

Results from a meta-analysis of 22 randomised controlled trials across Medline and the Cochrane Library have suggested that tirzepatide (Mounjaro

If you're experiencing symptoms of vitamin B12 deficiency or are interested in the potential benefits of B12 injections, it's best to discuss your options with a healthcare professional

Finerenone in heart failure and chronic kidney disease with type 2 diabetes: FINE-HEART pooled analysis of cardiovascular kidney and mortality outcomes